Skip to content

Body temperature-sensitive hydrogel based on green propolis for the auxiliary treatment of periodontal diseases

Thermosensitive Green Propolis hydrogel for use as an adjunct to periodontal treatment: clinical and laboratory analysis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8fdcbc3
Enrollment
Unknown
Registered
2025-10-06
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

This is an interventional, experimental, quantitative, and prospective study, comprising in vitro preclinical phases and a randomized, controlled, parallel, three-arm clinical trial (propolis hydrogel
chlorhexidine hydrogel — positive control, with a total of 15 patients
placebo hydrogel/saline irrigation — negative control, with a total of 45 patients), resulting in a total of 90 patients, double-blind, with follow-up at 21, 45, and 90 days. It is a study concerning

Sponsors

Universidade de São Paulo
Lead Sponsor
Universidade de São Paulo
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Both genders; with a minimum age of 18 years and no maximum age limit; minimum of 14 teeth present in the mouth (excluding third molars and teeth indicated for extraction); diagnosis of periodontitis stage 2 or 3 and grade B or C (at least 30% of teeth with at least one site with probing pocket depth (PPD) and clinical attachment level (CAL) equal or higher than 5 mm and bleeding on probing); systemically healthy patients; patients diagnosed with Diabetes Mellitus

Exclusion criteria

Exclusion criteria: Smoking, pregnancy; total edentulism; recent periodontal treatment; recent use of antibiotics; patients who refused to sign the consent form

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: When comparing pro-inflammatory cytokine levels between the study groups, it is expected that those concentrations decrease after treatment.

Secondary

MeasureTime frame
Expected outcome 2: When comparing anti-inflammatory cytokine levels between the study groups, it is expected that those concentrations increase after treatment.;Expected outcome 3: Regarding the product used, it is expected that the chlorhexidine and propolis gels will show superior post-treatment results compared to the placebo gel and saline solution.;Expected outcome 4: The propolis gel is expected to show clinical results comparable to those of the chlorhexidine gel, confirming its potential as an alternative for periodontal treatment.

Countries

Brazil

Contacts

Public ContactNathalya Moura

Universidade de São Paulo, Faculdade de Odontologia de Ribeirão Preto

nathalya_vilela@usp.br+55(16)3315-3000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)